Adverse effects of conventional DMARDs and biologic DMARDs
Suzuki, Y.; Saito, E.; Wakabayashi, T.; Suwa, A.
Nihon Rinsho. Japanese Journal of Clinical Medicine 65 Suppl. 8: 209-217
2007
ISSN/ISBN: 0047-1852 PMID: 18074541 Document Number: 607633
Document emailed within 1 workday
Related Documents
Menon, N.; Kothari, S.Y.; Gogna, A.; Sharma, R. 2014: Comparison of intra-articular glucocorticoid injections with DMARDs versus DMARDs alone in rheumatoid arthritis Journal of the Association of Physicians of India 62(8): 673-676Sugii, S. 2005: Adverse effects of DMARDs in treatment of rheumatoid arthritis Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 1): 566-572
Wacharapornin, P.; Suwannalai, P. 2014: Predictors for low disease activity and remission in rheumatoid arthritis patients treated with biological DMARDs Journal of the Medical Association of Thailand 97(11): 1157-1163
Vázquez, I.; Graell, E.; Gratacós, J.; Cañete, J.D.; Viñas, O.; Ercilla, M.G.; Gómez, A.; Hernández, M.V.; Rodríguez-Cros, J.R.; Larrosa, M.; Sanmartí, R. 2007: Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting Clinical and experimental rheumatology 25(2): 231-238
Narvaez, J.; Díaz-Torné, C.; Ruiz, J.M.; Hernandez, M.V.; Torrente-Segarra, V.; Ros, S.; Rodriguez de la Serna, A.; Díaz-López, C.; Sanmartí, R.; Nolla, J.M. 2011: Predictors of response to rituximab in patients with active rheumatoid arthritis and inadequate response to anti-TNF agents or traditional DMARDs Clinical and Experimental Rheumatology 29(6): 991-997
Janiec, W.; Pietryka, B.; Sliwiński, L.; Leszczyńska, J. 1985: Adverse effects of nonsteroid anti-inflammatory drugs. I. Adverse effects of salicylic, phenylacetic and propionic acids Wiadomosci Lekarskie 38(22): 1613-1619
Stricker, B.H.; Ottervanger, J.P.; van der Klauw, M.M. 1994: Registration of suspected adverse effects by the Bureau Adverse Effects Drugs; research activities in 1993 Nederlands Tijdschrift Voor Geneeskunde 138(42): 2110-2113
Gerdén, B. 2005: The Medical Products Agency about SSRi to pregnant women and adverse effects on the fetus. Long-term adverse effects are not proved, documentation is insufficient, more research is necessary Lakartidningen 102(10): 791
Janiec, W.; Pietryka, B.; Pytlik, M.; Leszczyńska, J. 1985: Adverse effects of non-steroidal anti-inflammatory drugs. II. Adverse effects of heterocyclic enols Wiadomosci Lekarskie 38(24): 1745-1750
Sepúlveda, B. 1970: Adverse effects of contraceptives. II. Adverse effects of contraceptive steroids on the liver Gaceta Medica de Mexico 100(8): 823-831
Bissonnette, R.; Kerdel, F.; Naldi, L.; Papp, K.; Galindo, C.; Langholff, W.; Tang, K.L.; Szapary, P.; Fakharzadeh, S.; Srivastava, B.; Goyal, K.; Gottlieb, A.B. 2017: Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis Journal of Drugs in Dermatology: Jdd 16(10): 1002-1013
Schneider, M.I.; Pineda, P.; Smagghe, G. 2006: Side effects of conventional and non-conventional insecticides on eggs and larvae of Chrysoperla externa (Hagen) (Neuroptera: Chrysopidae) in Argentine Communications in Agricultural and Applied Biological Sciences 71(2): 425-427
Gram, L.F. 1977: Adverse effects during treatment with beta receptor blockaders. Report from the Adverse Drug Reaction Committee 1968-1976 Ugeskrift for Laeger 139(35): 2065-2068
Papp, K.A.; Strober, B.; Augustin, M.; Calabro, S.; Londhe, A.; Chevrier, M.; Augustin, M.; Chevrier, M.; Fiorentino, D.; Gelfand, J.; Gordon, K.; Gottlieb, A.B.; Ho, V.; Kalb, R.; Kerdel, F.A.; Kimball, A.B.; Krueger, G.G.; Langley, R.; Lebwohl, M.; Leonardi, C.L.; Menter, A.; Naldi, L.; Papp, K.; Pariser, D.; Strober, B. 2012: PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents Journal of drugs in dermatology: JDD 11(10): 1210-1217
Jaźwińska-Tarnawska, E.; Wiela-Hojeńska, A.; Wolańczyk-Medrala, A.; Patkowski, J.; Nittner-Marszalska, M.; Głowacka, K. 2012: Monitoring of NSAIDs adverse effects based on spontaneous reports from Wrocław regional adverse drug reactions monitoring center Acta Poloniae Pharmaceutica 69(5): 979-984
Saito, A.; Yamaji, T.; Saigusa, M. 1986: Adverse effects of antimicrobiological agents and countermeasures--TDM and countermeasures against adverse effects Nihon Rinsho. Japanese Journal of Clinical Medicine 44(4): 955-958
Kahn, A. 1985: Biologic effects of alcohol Journal of the Arkansas Medical Society 81(12): 647-649
Edwards, K.M.; Lawrence, E.; Wright, P.F. 1986: Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components American Journal of Diseases of Children 140(9): 867-871
Lindgren, S.B.; Larsson, S. 1982: Inhalation of terbutaline sulphate through a conventional actuator or a pear-shaped tube: effects and side effects European Journal of Respiratory Diseases 63(6): 504-509
Brown, T.D. 1989: Biologic response modifiers: understanding biologic systems Texas Medicine 85(11): 4-5